Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation
- 30 June 2011
- journal article
- case report
- Published by Elsevier in Antiviral Research
- Vol. 90 (3) , 183-186
- https://doi.org/10.1016/j.antiviral.2011.03.184
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Antiviral Activities of Artemisinin and ArtesunateClinical Infectious Diseases, 2008
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging studyBlood, 2008
- Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2008
- Optimization of an LC-MS Method for the Determination of Artesunate and Dihydroartemisinin Plasma Levels using Liquid-Liquid ExtractionJournal of Analytical Toxicology, 2008
- Multidrug Resistance Conferred by Novel DNA Polymerase Mutations in Human Cytomegalovirus IsolatesAntimicrobial Agents and Chemotherapy, 2007
- The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivoAntiviral Research, 2006
- Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegalovirusesJournal of Molecular Medicine, 2001
- Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomesBlood, 2001
- The Dynamics of Human Cytomegalovirus Replication in VivoThe Journal of Experimental Medicine, 1999
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998